BRPI0923402A2 - Peptídeos c10rf59 e vacinas incluindo os mesmos. - Google Patents
Peptídeos c10rf59 e vacinas incluindo os mesmos.Info
- Publication number
- BRPI0923402A2 BRPI0923402A2 BRPI0923402-0A BRPI0923402A BRPI0923402A2 BR PI0923402 A2 BRPI0923402 A2 BR PI0923402A2 BR PI0923402 A BRPI0923402 A BR PI0923402A BR PI0923402 A2 BRPI0923402 A2 BR PI0923402A2
- Authority
- BR
- Brazil
- Prior art keywords
- c10rf59
- peptides
- same
- vaccines including
- vaccines
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0635—B lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
- C12N5/0638—Cytotoxic T lymphocytes [CTL] or lymphokine activated killer cells [LAK]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008327358 | 2008-12-24 | ||
US14591209P | 2009-01-20 | 2009-01-20 | |
PCT/JP2009/006944 WO2010073551A1 (en) | 2008-12-24 | 2009-12-17 | C1orf59 peptides and vaccines including the same |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0923402A2 true BRPI0923402A2 (pt) | 2015-08-04 |
Family
ID=42287204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0923402-0A BRPI0923402A2 (pt) | 2008-12-24 | 2009-12-17 | Peptídeos c10rf59 e vacinas incluindo os mesmos. |
Country Status (14)
Country | Link |
---|---|
US (2) | US8735361B2 (pt) |
EP (1) | EP2382314A4 (pt) |
JP (1) | JP5728716B2 (pt) |
KR (1) | KR20110117112A (pt) |
CN (2) | CN104193816A (pt) |
AU (1) | AU2009332389A1 (pt) |
BR (1) | BRPI0923402A2 (pt) |
CA (1) | CA2747686A1 (pt) |
IL (1) | IL213318A0 (pt) |
MX (1) | MX2011006755A (pt) |
RU (1) | RU2011130796A (pt) |
SG (1) | SG172374A1 (pt) |
TW (1) | TW201030018A (pt) |
WO (1) | WO2010073551A1 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0923402A2 (pt) | 2008-12-24 | 2015-08-04 | Oncotherapy Science Inc | Peptídeos c10rf59 e vacinas incluindo os mesmos. |
WO2011161960A1 (en) * | 2010-06-23 | 2011-12-29 | Oncotherapy Science, Inc. | C1orf59 for target genes of cancer therapy and diagnosis |
WO2013133405A1 (ja) | 2012-03-09 | 2013-09-12 | オンコセラピー・サイエンス株式会社 | ペプチドを含む医薬組成物 |
DK2895600T3 (da) | 2012-09-11 | 2020-04-27 | Onco Therapy Science Inc | Ube2t-peptider og vacciner, der indeholder disse |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997044667A2 (fr) * | 1996-05-21 | 1997-11-27 | Institut Pasteur | Methodes d'utilisation de complexes peptide/complexe majeur d'histocompatibilite pour obtenir ou purifier des cellules t antigene-specifiques et pour stimuler des cellules t |
KR100669065B1 (ko) * | 2001-04-03 | 2007-01-15 | 다카라 바이오 가부시키가이샤 | 세포상해성 t 림프구 |
US20040142325A1 (en) * | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
WO2003063770A2 (en) | 2001-11-07 | 2003-08-07 | Mannkind Corporation | Expression vectors encoding epitopes of target-associated antigens and methods for their design |
EP2267021B1 (en) | 2002-09-12 | 2015-02-18 | Oncotherapy Science, Inc. | KDR peptides and vaccines comprising the same |
TWI324608B (en) | 2003-02-28 | 2010-05-11 | Oncotherapy Science Inc | Genes and polypeptides relating to human colorectal cancers |
WO2005005631A1 (ja) * | 2003-07-11 | 2005-01-20 | Dainippon Sumitomo Pharma Co., Ltd. | リビン由来のhla-a24結合性癌抗原ペプチド |
JP4628208B2 (ja) * | 2004-08-10 | 2011-02-09 | オンコセラピー・サイエンス株式会社 | Cxadrl1またはgcud1タンパク質を発現する胃癌または結腸直腸癌の治療のためのペプチドワクチン |
KR20080013850A (ko) * | 2005-02-08 | 2008-02-13 | 더 카운실 오브 더 퀸즐랜드 인스티튜트 오브 메디컬 리서치 | 면역원성 분자 |
ES2364670T3 (es) | 2005-02-25 | 2011-09-12 | Oncotherapy Science, Inc. | Vacunas de péptidos para cánceres de pulmón que expresan polipéptidos ttk. |
CN1948342B (zh) * | 2005-10-14 | 2010-12-29 | 中国人民解放军第二军医大学 | 一种新的候选癌基因hRabJ来源的HLA-A2限制性表位多肽及其应用 |
TWI441648B (zh) * | 2007-01-03 | 2014-06-21 | Oncotherapy Science Inc | Foxp3胜肽疫苗 |
US20100120628A1 (en) * | 2007-02-06 | 2010-05-13 | Genizon Biosciences Inc. | Genemap of the human genes associated with adhd |
TWI610939B (zh) * | 2007-02-21 | 2018-01-11 | 腫瘤療法 科學股份有限公司 | 表現腫瘤相關抗原之癌症的胜肽疫苗 |
BRPI0923402A2 (pt) | 2008-12-24 | 2015-08-04 | Oncotherapy Science Inc | Peptídeos c10rf59 e vacinas incluindo os mesmos. |
-
2009
- 2009-12-17 BR BRPI0923402-0A patent/BRPI0923402A2/pt not_active IP Right Cessation
- 2009-12-17 US US13/141,389 patent/US8735361B2/en not_active Expired - Fee Related
- 2009-12-17 AU AU2009332389A patent/AU2009332389A1/en not_active Abandoned
- 2009-12-17 CN CN201410336021.0A patent/CN104193816A/zh active Pending
- 2009-12-17 KR KR1020117017449A patent/KR20110117112A/ko not_active Application Discontinuation
- 2009-12-17 MX MX2011006755A patent/MX2011006755A/es active IP Right Grant
- 2009-12-17 EP EP09834363A patent/EP2382314A4/en not_active Withdrawn
- 2009-12-17 RU RU2011130796/10A patent/RU2011130796A/ru not_active Application Discontinuation
- 2009-12-17 CA CA2747686A patent/CA2747686A1/en not_active Abandoned
- 2009-12-17 WO PCT/JP2009/006944 patent/WO2010073551A1/en active Application Filing
- 2009-12-17 SG SG2011046497A patent/SG172374A1/en unknown
- 2009-12-17 JP JP2011527091A patent/JP5728716B2/ja not_active Expired - Fee Related
- 2009-12-17 CN CN200980157412.3A patent/CN102333867B/zh not_active Expired - Fee Related
- 2009-12-22 TW TW098144135A patent/TW201030018A/zh unknown
-
2011
- 2011-06-02 IL IL213318A patent/IL213318A0/en unknown
-
2014
- 2014-03-06 US US14/199,784 patent/US20140199335A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2382314A4 (en) | 2013-03-06 |
US20120003253A1 (en) | 2012-01-05 |
EP2382314A1 (en) | 2011-11-02 |
CN102333867B (zh) | 2015-01-14 |
TW201030018A (en) | 2010-08-16 |
MX2011006755A (es) | 2011-07-20 |
AU2009332389A1 (en) | 2011-07-14 |
IL213318A0 (en) | 2011-07-31 |
KR20110117112A (ko) | 2011-10-26 |
US8735361B2 (en) | 2014-05-27 |
RU2011130796A (ru) | 2013-01-27 |
CN104193816A (zh) | 2014-12-10 |
JP5728716B2 (ja) | 2015-06-03 |
US20140199335A1 (en) | 2014-07-17 |
WO2010073551A1 (en) | 2010-07-01 |
CN102333867A (zh) | 2012-01-25 |
SG172374A1 (en) | 2011-07-28 |
CA2747686A1 (en) | 2010-07-01 |
JP2012513742A (ja) | 2012-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0914782A2 (pt) | peptídeos de epítopos de cdca1 e vacinas contendo os mesmos | |
BRPI0909770A2 (pt) | Vacina, e, kit | |
ITMI20120590A1 (it) | Girante e turbomacchinario includente la girante. | |
BRPI0923231A2 (pt) | anticorpo anti-cmet. | |
DK1968631T3 (da) | Vaccine | |
BR112012002349A2 (pt) | composto,e, uso do mesmo | |
BRPI0818288A2 (pt) | Proteínas conjugadas e peptídeos. | |
BRPI0821276A2 (pt) | Produto, e, uso do produto | |
DK2114993T3 (da) | Vaccine | |
CR10571A (es) | Vacuna virica recombinante | |
BR112012004335A2 (pt) | composto, composição farmacêutica, e, uso do composto. | |
BRPI0811021A2 (pt) | Peptídeos e vacinas de tem8 compreendendo os mesmos | |
BRPI1008887A2 (pt) | peptídeos de foxm1 e vacinas contendo os mesmo | |
BRPI0915367A2 (pt) | peptídeos e epítopos anti-p2x7 | |
BRPI1009301A2 (pt) | peptídeos neil 3 e vacinas incluindo os mesmos | |
BRPI0917391A2 (pt) | peptídeo de epítodo de hig2 e urlc10 e vacinas contendo o mesmo | |
BRPI0913175A2 (pt) | artigo antibalístico, e, uso do mesmo. | |
FR2919810B1 (fr) | Objet volant. | |
BRPI0916940A2 (pt) | peptídeos de epítopo de melk e vacinas contendo os mesmos. | |
BRPI0923402A2 (pt) | Peptídeos c10rf59 e vacinas incluindo os mesmos. | |
BRPI0919766A2 (pt) | peptídeo de epítopo de rab6kifl/kif20a e vacinas contendo o mesmo | |
BRPI1013938A2 (pt) | "peptídeos ttk e vacinas incluindo os mesmos" | |
BR112012002311A2 (pt) | composto, composição farmacêutica, e, uso do composto. | |
BRPI1012312A2 (pt) | peptídeos vangl1 e vacinas incluindo os mesmos | |
BR112013013158A2 (pt) | peptídeos de tomm34 e vacinas incluindo os mesmos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |